D. E. Shaw & Co., Inc. - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 38 filers reported holding EDGE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$238,000
-61.8%
743,756
-2.1%
0.00%
-100.0%
Q3 2018$623,000
-29.4%
759,721
-11.3%
0.00%0.0%
Q2 2018$883,000
+2053.7%
856,666
+2350.3%
0.00%
Q1 2018$41,000
-85.0%
34,962
+20.1%
0.00%
Q4 2017$273,000
-1.1%
29,117
+13.2%
0.00%
Q3 2017$276,000
+16.9%
25,719
+11.7%
0.00%
Q2 2017$236,000
-7.8%
23,020
-18.2%
0.00%
Q1 2017$256,000
+12.8%
28,135
+54.8%
0.00%
Q4 2016$227,000
+102.7%
18,174
+48.3%
0.00%
Q1 2016$112,000
-73.8%
12,256
-64.2%
0.00%
-100.0%
Q4 2015$428,00034,2570.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders